Prodia Diagnostic Line is trading at IDR 228.00, up 16.33%, in an unexplained rebound; September 23 coverage identifies no direct catalyst.
- The stock recovered from IDR 196.00 on September 22, 2026.
- Coverage identifies no new company announcement, earnings update, analyst action, or other direct catalyst.
- Recent commentary describes post-IPO correction and base formation. Confidence is low because external market data conflicts with the supplied price context.